Therapeutic Drug Monitoring to Individualize the Dosing of Pazopanib: A Pharmacokinetic Feasibility Study

D. de Wit; N.P. van Erp; J Den Hartigh; R. Wolterbeek; M. van Deursen; M. Labots; H.J. Guchelaar; H.M. Verheul; H. Gelderblom

doi:10.1097/FTD.0000000000000141

Therapeutic Drug Monitoring to Individualize the Dosing of Pazopanib: A Pharmacokinetic Feasibility Study

D. de Wit, N.P. van Erp, J Den Hartigh, R. Wolterbeek, M. van Deursen, M. Labots, H.J. Guchelaar, H.M. Verheul, H. Gelderblom

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	331-338
Journal	Therapeutic Drug Monitoring
Volume	37
Issue number	3
DOIs	https://doi.org/10.1097/FTD.0000000000000141
Publication status	Published - 2015

Access to Document

10.1097/FTD.0000000000000141

Cite this

@article{74d8a191d21646c098372bc3bf353855,

title = "Therapeutic Drug Monitoring to Individualize the Dosing of Pazopanib: A Pharmacokinetic Feasibility Study",

author = "{de Wit}, D. and {van Erp}, N.P. and {Den Hartigh}, J and R. Wolterbeek and {van Deursen}, M. and M. Labots and H.J. Guchelaar and H.M. Verheul and H. Gelderblom",

year = "2015",

doi = "10.1097/FTD.0000000000000141",

language = "Undefined/Unknown",

volume = "37",

pages = "331--338",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Therapeutic Drug Monitoring to Individualize the Dosing of Pazopanib: A Pharmacokinetic Feasibility Study

AU - de Wit, D.

AU - van Erp, N.P.

AU - Den Hartigh, J

AU - Wolterbeek, R.

AU - van Deursen, M.

AU - Labots, M.

AU - Guchelaar, H.J.

AU - Verheul, H.M.

AU - Gelderblom, H.

PY - 2015

Y1 - 2015

U2 - 10.1097/FTD.0000000000000141

DO - 10.1097/FTD.0000000000000141

M3 - Article

C2 - 25271729

SN - 0163-4356

VL - 37

SP - 331

EP - 338

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 3

ER -